SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001513160-11-000020
Filing Date
2011-03-31
Accepted
2011-03-31 11:49:59
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 OXIS INTERNATIONAL 2010 ANNUAL REPORT annualreport2010.htm 10-K 1258232
2 CERTIFICATE OF AMENDMENT TO AMENDED & RESTATED CERTIFICATE OF INCORPORATION ex32.htm EX-3.2 6952
3 CERTIFICATE OF DESIGNATION OF SERIES I CONVERTIBLE PREFERRED STOCK ex34.htm EX-3.4 72143
4 2010 EQUITY INCENTIVE PLAN ex47.htm EX-4.7 84608
5 COMMITMENT LETTER DATED OCTOBER 13, 2010 ex1016.htm EX-10.16 45902
6 SERIES I PREFERRED STOCK PURCHASE AGREEMENT DATED OCTOBER 13, 2010 ex1017.htm EX-10.17 100060
7 FIRST AMENDMENT TO 0% CONVERTIBLE DEBENTURE DATED DECEMBER 23, 2010 ex1018.htm EX-10.18 19928
8 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex311.htm EX-31.1 13487
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex312.htm EX-31.2 13178
10 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex321.htm EX-32.1 5846
11 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex322.htm EX-32.2 5630
  Complete submission text file 0001513160-11-000020.txt   1627193
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-08092 | Film No.: 11724563
SIC: 2834 Pharmaceutical Preparations